Search research articles
Contact Us
Filters
Showing results (81-90 of 409) with videos related to
Page
of 41
Sort By:
Neurology
|
September 30, 2016
Physical activity and the incidence of multiple sclerosis
Kirsten S Dorans, Jennifer Massa, Tanuja Chitnis, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
February 6, 2023
Fronto-striatal damage may contribute to resistance to fatigue-lowering medications in multiple sclerosis
Miklos Palotai, Diana Pintye, Bonnie Glanz, et al.
The Lancet. Neurology
|
September 27, 2025
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications
Tanuja Chitnis, Roberta Magliozzi, Ahmed Abdelhak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 7, 2017
Agreement analysis comparing iPad LCVA and Sloan testing in multiple sclerosis patients
Neda Sattarnezhad, Samantha Farrow, Dorlan Kimbrough, et al.
Nutritional Neuroscience
|
March 5, 2021
Triad of hypovitaminosis A, hyperostosis, and optic neuropathy in males with autism spectrum disorders
Deena Godfrey, Robert T Stone, Marcus Lee, et al.
Scientific Reports
|
July 26, 2020
Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases
Shrishti Saxena, Hrishikesh Lokhande, Grace Gombolay, et al.
Multiple Sclerosis and Related Disorders
|
November 10, 2023
Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis
Negar Molazadeh, Tetsuya Akaishi, Gauruv Bose, et al.
Journal of the Neurological Sciences
|
January 22, 2011
Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis
Brian C Healy, David Engler, Taha Gholipour, et al.
Neurology
|
August 31, 2016
Pediatric multiple sclerosis: Escalation and emerging treatments
Tanuja Chitnis, Angelo Ghezzi, Barbara Bajer-Kornek, et al.
Journal of the American Society of Nephrology : JASN
|
March 28, 2003
A novel mechanism for the immunomodulatory functions of class II MHC-derived peptides
Barbara Murphy, Joyce Yu, Qingsheng Jiao, et al.
Page
of 41
Search research articles
Search
Showing results (81-90 of 409) with videos related to
Sort By:
Page
of 41
Neurology
|
September 30, 2016
Physical activity and the incidence of multiple sclerosis
Kirsten S Dorans, Jennifer Massa, Tanuja Chitnis, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
February 6, 2023
Fronto-striatal damage may contribute to resistance to fatigue-lowering medications in multiple sclerosis
Miklos Palotai, Diana Pintye, Bonnie Glanz, et al.
The Lancet. Neurology
|
September 27, 2025
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications
Tanuja Chitnis, Roberta Magliozzi, Ahmed Abdelhak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 7, 2017
Agreement analysis comparing iPad LCVA and Sloan testing in multiple sclerosis patients
Neda Sattarnezhad, Samantha Farrow, Dorlan Kimbrough, et al.
Nutritional Neuroscience
|
March 5, 2021
Triad of hypovitaminosis A, hyperostosis, and optic neuropathy in males with autism spectrum disorders
Deena Godfrey, Robert T Stone, Marcus Lee, et al.
Scientific Reports
|
July 26, 2020
Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases
Shrishti Saxena, Hrishikesh Lokhande, Grace Gombolay, et al.
Multiple Sclerosis and Related Disorders
|
November 10, 2023
Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis
Negar Molazadeh, Tetsuya Akaishi, Gauruv Bose, et al.
Journal of the Neurological Sciences
|
January 22, 2011
Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis
Brian C Healy, David Engler, Taha Gholipour, et al.
Neurology
|
August 31, 2016
Pediatric multiple sclerosis: Escalation and emerging treatments
Tanuja Chitnis, Angelo Ghezzi, Barbara Bajer-Kornek, et al.
Journal of the American Society of Nephrology : JASN
|
March 28, 2003
A novel mechanism for the immunomodulatory functions of class II MHC-derived peptides
Barbara Murphy, Joyce Yu, Qingsheng Jiao, et al.
Page
of 41